Skip to content

Public FDA record

Z-0941-2021: SARS-CoV-2 Antigen Test

Recall record Z-0941-2021 for Qiagen Sciences LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0941-2021
Company in FDA record
Qiagen Sciences LLC
FDA record creation date
Feb 1, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

QIAGEN has become aware of the potential for false positive results to occur with some patient samples.

Source facts

Action
On 01/13/2021, Qiagen issued Urgent Medical Device Correction notices to customers via phone and email. Customers were advised to do the following stop using the product and return any remaining product back to Qiagen.
Initiated
2021-01-15
Root cause
Under Investigation by firm
Terminated
2022-07-11
Distribution
Domestic: AZ, CA, DC, CO,FL,HI, IL, KY, MI, MO, NC, NJ, NM, NY, OH, RI, TX, WA, WY
Recall number
Z-0941-2021
Recall status
Terminated
CDRH record ID
185535
FDA record created
2021-02-01
Recall event number
87205

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗